Eagle Pharmaceuticals Inc
(EGRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 51,943 | 81,453 | 2,571 | N/A | -17,977 |
| Depreciation Amortization | 3,969 | 1,589 | 112 | N/A | 104 |
| Income taxes - deferred | 17,289 | -30,116 | 0 | N/A | N/A |
| Accounts receivable | -11,627 | -15,919 | -14,311 | N/A | -2,172 |
| Accounts payable and accrued liabilities | -8,460 | 10,668 | 356 | N/A | 2,867 |
| Other Working Capital | -29,569 | -8,694 | -16,725 | N/A | 2,851 |
| Other Operating Activity | 35,374 | 14,226 | 18,279 | 0 | 484 |
| Operating Cash Flow | $58,919 | $53,207 | $-9,718 | $N/A | $-13,843 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 0 | 0 | N/A | -19,999 |
| PPE Investments | -4,436 | -6,440 | -1,881 | N/A | -46 |
| Net Acquisitions | N/A | -25,110 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -750 | -14,250 | 0 | N/A | N/A |
| Other Investing Activity | -750 | -14,250 | 0 | 0 | 0 |
| Investing Cash Flow | $-5,186 | $-45,800 | $-1,881 | $N/A | $-20,045 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 50,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,250 | N/A | 0 | N/A | N/A |
| Common Stock Issued | 4,338 | 3,619 | 55,813 | N/A | 46,134 |
| Common Stock Repurchased | -43,792 | -37,003 | 0 | N/A | 0 |
| Other Financing Activity | -1,192 | -286 | 0 | 0 | 20 |
| Financing Cash Flow | $8,104 | $-33,670 | $55,813 | $N/A | $46,154 |
| Beginning Cash Position | 52,820 | 79,083 | 34,869 | N/A | 10,456 |
| End Cash Position | 114,657 | 52,820 | 79,083 | N/A | 22,722 |
| Net Cash Flow | $61,837 | $-26,263 | $44,214 | $N/A | $12,266 |
| Free Cash Flow | |||||
| Operating Cash Flow | 58,919 | 53,207 | -9,718 | N/A | -13,843 |
| Capital Expenditure | -4,436 | -1,590 | -1,881 | N/A | -46 |
| Free Cash Flow | 54,483 | 51,617 | -11,599 | 0 | -13,889 |